Anti-CD3 monoclonal antibody activated T cells (ATC) armed with anti-CD3 x anti-EGFR bispecific antibody (EGFR BiAb) target T cells to tumor-associated antigen (TAA) on solid tumors in a non-MHC restricted manner [13]. This evidence concerns the gene EGFR and neoplasm.